SPT Labtech, a leader in the design and development of automated instrumentation and consumables, has announced its acquisition by EQT IX Fund (EQT Private Equity), a purpose-driven global investment organisation, from current owners Battery Ventures.
Since 1997, SPT Labtech has designed and manufactured innovative solutions for liquid handling, sample preparation and management, transforming the way scientists do laboratory research by enabling greater productivity and efficiency. Headquartered in Melbourn, UK, the company has been owned by Battery Ventures since its spin-out from TTP Group in 2018.
Under Battery Ventures’ ownership, SPT Labtech has cemented its leading share in the low-throughput liquid-handling market, and has also strengthened and diversified its portfolio of products, expanded its geographic reach, and continued to create innovative automated solutions for genomics, multi-omics, drug discovery, cryo-EM, and other key life science applications.
The deal with EQT Private Equity will enable SPT Labtech to capitalise on this strong foundation of organic and acquisition-based growth and execute against an ambitious strategic vision for product innovation, geographic expansion, and targeting new end markets to address the evolving needs of the life science community.